z-logo
open-access-imgOpen Access
Cerebral correlates of psychotic syndromes in neurodegenerative diseases
Author(s) -
Jellinger Kurt A.
Publication year - 2012
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/j.1582-4934.2011.01311.x
Subject(s) - apathy , dementia , psychosis , disease , frontotemporal dementia , dementia with lewy bodies , psychology , neurochemical , neuroscience , pathological , lewy body , schizophrenia (object oriented programming) , cognition , psychiatry , neurocognitive , medicine , pathology
•  Introduction•  Old age and Alzheimer’s disease‐  Prevalence estimates‐  Clinical manifestations‐  Neuroimaging‐  Neuropathology•  Lewy body diseases‐  Clinical features and prevalence‐  Neuroimaging‐  Neuropathology‐  Huntington’s disease (HD)‐  Frontotemporal dementia (frontotemporal lobe degeneration [FLTD])‐  Prion diseases‐  Conclusions and future prospectsPsychosis has been recognized as a common feature in neurodegenerative diseases and a core feature of dementia that worsens most clinical courses. It includes hallucinations, delusions including paranoia, aggressive behaviour, apathy and other psychotic phenomena that occur in a wide range of degenerative disorders including Alzheimer’s disease, synucleinopathies (Parkinson’s disease, dementia with Lewy bodies), Huntington’s disease, frontotemporal degenerations, motoneuron and prion diseases. Many of these psychiatric manifestations may be early expressions of cognitive impairment, but often there is a dissociation between psychotic/behavioural symptoms and the rather linear decline in cognitive function, suggesting independent pathophysiological mechanisms. Strictly neuropathological explanations are likely to be insufficient to explain them, and a large group of heterogeneous factors (environmental, neurochemical changes, genetic factors, etc.) may influence their pathogenesis. Clinico‐pathological evaluation of behavioural and psychotic symptoms (PS) in the setting of neurodegenerative and dementing disorders presents a significant challenge for modern neurosciences. Recognition and understanding of these manifestations may lead to the development of more effective preventive and therapeutic options that can serve to delay long‐term progression of these devastating disorders and improve the patients’ quality of life. A better understanding of the pathophysiology and distinctive pathological features underlying the development of PS in neurodegenerative diseases may provide important insights into psychotic processes in general.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here